principal [50/mm:100/mm 3 . 38 69 Reinitiate secondary CMV prophylaxis if CD4 + T-cell count decreases to] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Manufacturers Mylan Pharmaceuticals Inc. Heritage Pharmaceuticals Inc. Drug Class Purine nucleosides Related Drugs CMV Retinitis Valcyte , valganciclovir , foscarnet , Foscavir , Cytovene , Vistide , More... Smallpox Vaccine Reaction vaccinia immune globulin , More... Cidofovir Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! every now and then
you are concerned Cidofovir gaining knowledge of
EmoticonEmoticon